title: [Severe malaria: assessment of the treatment of anaemia and cerebral manifestations in a tropical intensive cares unit].
authors.forename: A-D
authors.initials: AD
authors.lastname: Gbadoé
authors.forename: K
authors.initials: K
authors.lastname: Lawson-Evi
authors.forename: A
authors.initials: A
authors.lastname: Badayodi
authors.forename: A
authors.initials: A
authors.lastname: Géraldo
authors.forename: J
authors.initials: J
authors.lastname: Guédénon
authors.forename: P
authors.initials: P
authors.lastname: Akpako
authors.forename: F
authors.initials: F
authors.lastname: Agbéko
authors.forename: D-Y
authors.initials: DY
authors.lastname: Atakouma
mesh_terms: D000367:Age Factors; D000740:Anemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use; D000077549:Artemether; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D018592:Cross-Over Studies; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D015278:Intensive Care Units, Pediatric / Q000592:standards; D016779:Malaria, Cerebral / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D016778:Malaria, Falciparum / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D011379:Prognosis; D011787:Quality of Health Care; D011803:Quinine / Q000008:administration & dosage / Q000627:therapeutic use; D014037:Togo
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D011803:Quinine; D000077549:Artemether